The 20 Best Gastric Lymphoma Doctors Near Me in Maryland, US

Blanche Mavromatis, MD, specializes in hematology oncology and is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mavromatis completed her fellowship at Georgetown University Hospital, residency at Georgetown University Medical Center and medical degree from Thomas Jefferson University Medical College. Dr. Mavromatis is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. She is also highly rated in 67 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Mavromatis is board certified in American Board Of Internal Medicine. Dr. Mavromatis is currently accepting new patients.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant. Dr. Swinnen is board certified in American Board Of Internal Medicine.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Qamar Zaman is an Oncologist practicing medicine in Cumberland, Maryland. Dr. Zaman is rated as a Distinguished provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 71 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Thrombocytopenia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Bone Marrow Aspiration.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia. Dr. Fishman is board certified in American Board Of Internal Medicine.

Dr. Frederick P. Smith is a medical oncologist specializing in breast cancer at Sibley Memorial Hospital and an instructor at Johns Hopkins School of Medicine and Georgetown University School of Medicine. He has a private practice in Washington, D.C. He is affiliated with Sibley Memorial Hospital and Suburban Hospital. Dr. Smith earned his medical degree from Saint Louis University School of Medicine. He completed a residency in internal medicine at Georgetown University Hospital, followed by a fellowship in oncology. Dr. Smith was named a 2012 Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly, as well as a Top MD by Consumers’ Checkbook Magazine. Prior to joining Johns Hopkins, Dr. Smith was the director of extramural oncology research at Georgetown University. In this position, he contributed over 50 articles to peer-reviewed medical journals. Dr. Smith is an integral advocate in the community for promoting access to clinical research. He has also contributed to clinical trials. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma. Dr. Smith is board certified in American Board Of Internal Medicine.

Yudhishtra Markan is a Hematologist Oncology specialist and an Oncologist practicing medicine in Glen Burnie, Maryland. Dr. Markan is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Markan is board certified in American Board Of Internal Medicine.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Garg is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura. Dr. Garg is board certified in American Board Of Internal Medicine.

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

Paul Faucher, DO, specializes in diagnostic radiology and is board certified in diagnostic radiology by the American Board of Radiology. He practices at UPMC Western Maryland, UPMC Western Maryland Outpatient Diagnostic Center, and Allegany Imaging, PC - Potomac Valley Hospital and is affiliated with UPMC Somerset. Dr. Faucher completed his medical education at Kansas City University of Medicine & Bioscience, residency at Fitzsimons Army Medical Center, and fellowship at William S Hall Psychiatric Institute. Dr. Faucher is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Breast Lump, Boils, Vertigo, and Carbuncle. Dr. Faucher is board certified in American Board Of Radiology.

Richard J. Jones, M.D., is a Professor of Oncology and Medicine, Director of the Bone Marrow Transplantation Program, and Co-Director of the Hematologic Malignancies Program at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Jones received his Bachelor of Science in chemistry from Bucknell University prior to completing his medical degree at the Temple University School of Medicine. He then completed his residency at Temple University Hospital, where he was appointed to serve as Chief Resident in Internal Medicine. Dr. Jones later came to Johns Hopkins to complete his Medical Oncology Fellowship, and was then recruited to the faculty. Dr. Jones’ research is aimed at better understanding the biology of normal and cancer stem cells, with the goal of translating promising findings to the clinic particularly in the area of blood and marrow transplantation (BMT). Dr. Jones' laboratory discovered one the most commonly-used stem cell markers, Aldefluor which identifies cells based on their expression of aldehyde dehydrogenase 1 (ALDH1), and have used this marker to identify and characterize normal stem cells and cancer stem cells from many hematologic malignancies. This work also led to the development of post-transplant cyclophosphamide and effective related haploidentical BMT. Cyclophosphamide is metabolized by ALDH1, which is the reason both stem cells and memory lymphocytes are resistant to the drug. Recently, Dr. Jones' laboratory found that cytochrome P450 enzymes are a major mechanism by which the bone marrow stem cell niche protects both normal and leukemia stem cells. Dr. Jones co-leads the Hematologic Malignancies and Bone Marrow Transplantation Research Program. In addition to his promising work in the laboratory, Dr. Jones is recognized as a gifted mentor. During his tenure at Hopkins, he has trained a generation of leading physician-scientists who have excelled at Johns Hopkins and across the country. Dr. Jones has also authored numerous peer-reviewed articles that have been published in such prestigious journals as Blood, Nature, the New England Journal of Medicine, Lancet, PNAS, the Annals of Internal Medicine, the Journal of Clinical Oncology, the Journal of the National Cancer Institute, the British Journal of Haematology, and Leukemia. Dr. Jones is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Non-Hodgkin Lymphoma, and Myelodysplastic Syndrome (MDS). Dr. Jones is board certified in American Board Of Internal Medicine.

Dr. Kronthal joins the Johns Hopkins Community Radiology division from Drs. Groover, Christie and Merritt (GCM), where he has practiced at both Sibley and Suburban Hospitals for more than eleven years. He received his Bachelor of Arts at Haverford College in 1983 and medical degree at the University of Virginia in 1987. Dr. Kronthal performed both his radiology residency and Body Imaging fellowship at Johns Hopkins Hospital from 1998 through 1993. Following his fellowship, he spent twelve years with WBA Imaging, during which time he served as Chairman of the Department of Imaging at Prince George’s Hospital Center. Dr. Kronthal was with GCM from 2005 – 2017 and is the incoming Chairman of Radiology at Sibley Hospital. He is a past president of the District of Columbia Metropolitan Radiological Society. He was awarded fellowship in the American College of Radiology in 2005. Dr. Kronthal is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Pleurisy, Pleural Effusion, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Kronthal is board certified in American Board Of Radiology.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia. Dr. Mener is board certified in American Board Of Internal Medicine.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Sastry is board certified in American Board Of Internal Medicine.

Dr. Brian G. Johnson is the chief of interventional radiology at Sibley Memorial Hospital. Dr. Johnson practices out of Sibley Memorial Hospital in Washington, D.C., Suburban Hospital in Bethesda, MD and the Johns Hopkins Hospital in Baltimore, MD. Dr. Johnson graduated summa cum laude from University of Minnesota prior to earning his medical degree from Johns Hopkins University School of Medicine. He completed a residency in physical medicine and rehabilitation at Sinai Hospital of Baltimore, as well as a residency in diagnostic radiology at the University of Maryland Medical Center. Dr. Johnson also completed an interventional radiology fellowship at Johns Hopkins University. Dr. Johnson has been repeatedly named a Top Doctor by Washingtonian Magazine, as well as a Top MD by Consumers' Checkbook Magazine. He is a member of the American College of Radiology and the Society of Interventional Radiology. Videos Brian Johnson, M.D.Interventional Radiology Selected Publications Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in the rabbit isolated vas deferentia, Johnson BG, Trachte GJ, Drewett JG, J Pharm & Exp Ther - 1/1/1991 Percutaneous Management of Renal and Renal-Pancreas Transplant Recipients Using CT Fluoroscopy: A Two Year Experience. Krebs TL, Johnson BG, Daly BD, Wong-You-Chong JJ, Bartlett ST, Radiological Society of North America Meeting, Chicago, IL - 1/29/1998 The hexagonal cell nitinol intravascular stent: a comparison of the effects of varying the stent wire gauge on the aorta and inferior vena cava in the swine animal model. Kuo J, Johnson BG, Venbrux AC, Olson JL, Samphilipo MA, Magee CA, Kobelja MA, Anderson JH, Osterman FA, American Roentgen Ray Society Annual Meeting, New Orleans, LA - 1/24/1994 The role of anticoagulation in the setting of a tethered vena cava filter in the swine animal model. Johnson BG, Reichle RL, Venbrux AC, Samphilipo MA, Magee CA, Anderson JH, Osterman FA, Society for Cardiovascular and Interventional Radiology Annual Meeting, Fort Lauderdale, FL - 1/1/1995. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Bile Duct Obstruction, Bone Graft, and Vertebroplasty. Dr. Johnson is board certified in American Board Of Radiology.

Peter Libby is a Neuroradiologist practicing medicine in Salisbury, Maryland. Dr. Libby is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Stroke, Bronchogenic Cyst, Gallbladder Disease, Bone Graft, and Vertebroplasty.

B.S., Massachusetts Institute of Technology M.D., University of Pennsylvania School of Medicine M.B.A., Carey School of Business at Johns Hopkins. Dr. Fuchs is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Fuchs is board certified in American Board Of Internal Medicine.

Dr. Abhishek Srinivas received his medical degree from the Johns Hopkins School of Medicine in 2006. He completed his diagnostic radiology residency at the Montefiore Medical Center of the Albert Einstein College of Medicine in New York in 2011. This was followed by a fellowship in Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine in 2012. Prior to joining Johns Hopkins as faculty, Dr. Srinivas established an interventional oncology practice serving much of central New Jersey, and a local hub for patients affiliated with Hahnemann University Hospital’s liver transplant program in Philadelphia. During this time, Dr. Srinivas was also part of the neuroradiology team for the hospital’s stroke center. His primary areas of expertise include interventional oncology (liver, kidney and bone cancers), vascular disease (deep vein thrombosis, pulmonary embolism, aneurysm treatment), uterine fibroid embolization, spine interventions, and advanced biliary interventions. Other interests include novel device evaluation and development. Videos Abhishek Srinivas, M.D. Selected Publications Chang SW, Srinivas A, Murphy KP. Chapter 5: Endovascular Management of a Patient After SAH. Bhardwaj A, Alkayed NJ, Kirsch JR, et al. Acute Stroke: Bench to Bedside. Chapter 5, 53 – 61. New York: Marcel Dekker. Copyright 2007, informa Healthcare USA inc. Farinhas, J, Srinivas A, Gulko E, Bello J. Chapter 4: Imaging of the Spine and Spinal Cord. Kirshblum S, Campagnolo D, DeLisa JA, Spinal Cord Medicine 2nd Edition. Lippincott, Williams, & Wilkins (Copyright 2011) Gailloud P, Srinivas A, Chang SW, Murphy KP. Morgan RH. Percutaneous Vertebroplasty in a Sitting Patient. Journal of Vascular and Interventional Radiology. 2005 Nov; 16(11):1558-9 Mahadevia AA, Weiland D, Kvamme P, Murphy KP, Srinivas A, Wyse G. Polymethylmethacrylate contact dermatitis after vertebroplasty. Journal of Vascular and Interventional Radiology 2007 Apr;18(4):585 Srinivas A, Chang SW, Gailloud P. Chapter 33: Diagnosis and Treatment of Cerebral Arteriovenous Malformations. Bhardwaj A, Alkayed NJ, Kirsch JR, et al. Acute Stroke: Bench to Bedside. Chapter 33, 397 – 404. New York: Marcel Dekker. Copyright 2007, informa Healthcare USA inc. Dr. Srinivas is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Ascites, Jaundice, Liver Embolization, and Bone Graft. Dr. Srinivas is board certified in American Board Of Radiology.

Arun Bhandari, M.D. is a native of Maryland and grew up in Silver Spring area. He earned his medical degree from Punjabi University and Government Medical College, Punjab, India and completed his internship and residency in Internal Medicine at New York University program in Queens, NY. He completed his Hematology and Oncology fellowship at University of Tennessee Health Science Center, Memphis, TN, Georgetown University and Washington Hospital Center, Washington, DC and NHLBI at National Institute of Health, Bethesda, MD. He served as a chief fellow at Georgetown University and Washington Hospital Center, Washington, D.C. After completing his fellowship in 2005, he joined as faculty at Allegheny General Hospital in Pittsburgh, PA, where he was actively involved in teaching fellows and residents. He joined COHA in 2007 at which time he opened a location in Annapolis and Kent Island. He has interest in head and neck cancer, brain cancer, breast cancer, lung cancer, gastrointestinal cancer(colon, pancreas, liver, gastric, esophageal etc.), genitourinary cancer (kidney, prostate, bladder etc.), gynecological cancer (ovarian, uterine, cervical, vaginal etc.), skin cancer, Lymphoma, Myeloma, Leukemia and various other blood disorders. He is a member of the American Society of Clinical Oncology and American Society of Hematology. He currently sees patients at Annapolis Cancer Center and Kent Island Center. He speaks English, Hindi, and Punjabi. Dr. Bhandari is rated as an Experienced provider by MediFind in the treatment of Gastric Lymphoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Multiple Myeloma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Bhandari is board certified in American Board Of Internal Medicine.